Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Related Articles by Review for PubMed (Select 15692967)

1.

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.

Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP; Scleroderma Lung Study Group.

Arthritis Rheum. 2005 Feb;52(2):592-600.

2.

Health-related quality of life in systemic sclerosis: a systematic review.

Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M; Canadian Scleroderma Research Group.

Arthritis Rheum. 2009 Aug 15;61(8):1112-20. doi: 10.1002/art.24676. Review.

3.

Surgical therapy for chronic obstructive pulmonary disease.

Martinez FJ, Chang A.

Semin Respir Crit Care Med. 2005 Apr;26(2):167-91. Review.

PMID:
16088435
5.

Interstitial lung disease in systemic sclerosis.

Kaloudi O, Miniati I, Alari S, Matucci-Cerinic M.

Intern Emerg Med. 2007 Dec;2(4):250-5. doi: 10.1007/s11739-007-0075-1. Epub 2007 Dec 17. Review.

PMID:
18172592
6.

[Pulmonary involvement in sclerodermia].

Paone G, Di Michele L, Mattia P, Tonnarini R, Lucifora V, Fiorucci F.

Minerva Med. 1994 Jun;85(6):293-300. Review. Italian.

PMID:
8084431
7.

Systemic sclerosis. A clinical overview.

Generini S, Fiori G, Moggi Pignone A, Matucci Cerinic M, Cagnoni M.

Adv Exp Med Biol. 1999;455:73-83. Review.

PMID:
10599326
8.

Evaluation and management of alveolitis and interstitial lung disease in scleroderma.

Latsi PI, Wells AU.

Curr Opin Rheumatol. 2003 Nov;15(6):748-55. Review.

PMID:
14569205
9.

Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).

Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O; Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis.

J Rheumatol. 2011 Nov;38(11):2419-27. doi: 10.3899/jrheum.110344. Epub 2011 Oct 1. Review.

PMID:
21965635
10.

Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials.

Au K, Khanna D, Clements PJ, Furst DE, Tashkin DP.

Curr Rheumatol Rep. 2009 Apr;11(2):111-9. Review.

PMID:
19296883
11.

Cyclophosphamide for scleroderma lung disease: a systematic review and meta-analysis.

Poormoghim H, Moradi Lakeh M, Mohammadipour M, Sodagari F, Toofaninjed N.

Rheumatol Int. 2012 Aug;32(8):2431-44. doi: 10.1007/s00296-011-1967-y. Epub 2011 Jun 21. Review.

PMID:
21691743
12.

Lung-volume reduction surgery for severe emphysema: appraisal of its current status.

Trow TK.

Curr Opin Pulm Med. 2004 Mar;10(2):128-32. Review.

PMID:
15021182
13.

Pulmonary manifestations of scleroderma.

Arroliga AC, Podell DN, Matthay RA.

J Thorac Imaging. 1992 Mar;7(2):30-45. Review.

PMID:
1578524
14.

Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.

Kowal-Bielecka O, Kowal K, Highland KB, Silver RM.

Semin Arthritis Rheum. 2010 Aug;40(1):73-88. doi: 10.1016/j.semarthrit.2008.10.009. Epub 2009 Jan 18. Review.

PMID:
19152959
15.

Interstitial lung disease in systemic sclerosis.

Bussone G, Mouthon L.

Autoimmun Rev. 2011 Mar;10(5):248-55. doi: 10.1016/j.autrev.2010.09.012. Epub 2010 Sep 21. Review.

PMID:
20863911
16.

Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.

Sahhar J, Littlejohn G, Conron M.

Intern Med J. 2004 Nov;34(11):626-38. Review.

PMID:
15546457
17.

Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature.

Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M, Matucci-Cerinic M, Szücs G, Shapira Y, Szekanecz Z, Shoenfeld Y.

Autoimmun Rev. 2011 Jun;10(8):490-4. doi: 10.1016/j.autrev.2011.02.002. Epub 2011 Feb 12. Review.

PMID:
21320645
18.

Assessment of dyspnea in advanced cancer patients.

Mancini I, Body JJ.

Support Care Cancer. 1999 Jul;7(4):229-32. Review.

PMID:
10423048
19.

Improving health-related quality of life in chronic obstructive pulmonary disease.

Santo Tomas LH, Varkey B.

Curr Opin Pulm Med. 2004 Mar;10(2):120-7. Review.

PMID:
15021181
20.

Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials.

Khanna D, Brown KK, Clements PJ, Elashoff R, Furst DE, Goldin J, Seibold JR, Silver RM, Tashkin DP, Wells AU.

Clin Exp Rheumatol. 2010 Mar-Apr;28(2 Suppl 58):S55-62. Epub 2010 Jun 24. Review.

PMID:
20576216
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk